Arriving in the arena of excess body fat management, retatrutide represents a unique strategy. Unlike many current medications, retatrutide functions as a double agonist, concurrently affecting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) sensors. This simultaneous engagement fosters several advantageous effect… Read More